DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,426,447 | -20.4% | 382,416 | 0.0% | 0.04% | -10.6% |
| Q2 2023 | $4,302,180 | +35.7% | 382,416 | +39.0% | 0.05% | +30.6% |
| Q1 2023 | $3,169,889 | -0.6% | 275,164 | 0.0% | 0.04% | -5.3% |
| Q4 2022 | $3,189,151 | -8.8% | 275,164 | 0.0% | 0.04% | -11.6% |
| Q3 2022 | $3,495,000 | +201.8% | 275,164 | +63.3% | 0.04% | +230.8% |
| Q2 2022 | $1,158,000 | -28.7% | 168,500 | 0.0% | 0.01% | -7.1% |
| Q1 2022 | $1,624,000 | -18.9% | 168,500 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $2,003,000 | -26.8% | 168,500 | 0.0% | 0.02% | -23.8% |
| Q3 2021 | $2,736,000 | -22.8% | 168,500 | 0.0% | 0.02% | -22.2% |
| Q2 2021 | $3,545,000 | +128.3% | 168,500 | +68.5% | 0.03% | +125.0% |
| Q1 2021 | $1,553,000 | -26.0% | 100,000 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $2,100,000 | -48.0% | 100,000 | -50.0% | 0.02% | -57.9% |
| Q3 2020 | $4,038,000 | – | 200,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |